| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $2.96B | +18.4% |
| Cost of Revenue | $1.95B | +15.6% |
| Gross Profit | $1.01B | +24.1% |
| R&D Expense | $79.4M | +87.4% |
| SG&A Expense | $290.3M | +58.2% |
| Operating Income | $639.1M | +8.9% |
| Pre-tax Income | $648.0M | +6.6% |
| Income Tax | $130.8M | +17.0% |
| Net Income | $509.2M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $766.1M | +61.6% |
| Accounts Receivable | $472.5M | +23.5% |
| Inventory | $209.4M | +3.8% |
| Current Assets | $2.16B | +22.0% |
| Total Assets | $3.19B | +26.7% |
| Current Liabilities | $1.03B | +15.9% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $655.8M | +52.9% |
| Capital Expenditures | $33.9M | +450.7% |
| Investing Cash Flow | -$186.1M | -2694.2% |
| Financing Cash Flow | -$177.6M | -127.0% |
| Free Cash Flow | $621.9M | +47.1% |
| +66.3% |
| EPS (Basic) | $3.55 | -10.6% |
| EPS (Diluted) | $3.47 | +3.0% |
| Total Liabilities |
| $1.56B |
| +2.5% |
| Stockholders' Equity | $1.63B | +69.4% |